Plain-English translation of NCT05859750 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a new medication that works by boosting your immune system to fight cancer cells, combined with standard chemotherapy treatments. Researchers want to see if this combination is safe and effective as a first-line treatment—meaning the first treatment you receive—for pancreatic cancer that has spread or cannot be surgically removed. Your medical team will monitor you closely throughout the study to watch how well the medication works and any side effects you may experience.
Pancreatic cancer is very difficult to treat, and current chemotherapy alone doesn't work well enough for many patients. This medication uses a different approach by helping your own immune system recognize and attack cancer cells, and researchers hope combining it with chemotherapy will be more effective than chemotherapy alone.
You likely qualify if…
You likely don't qualify if…
You will receive intravenously (through an IV) combined with one of several standard chemotherapy regimens, depending on which group you are assigned to. You will visit the research clinic regularly for infusions, blood tests, and imaging scans to monitor your cancer and watch for side effects. The study will continue as long as the treatment is helping and you are tolerating it well, and your medical team will be in close contact with you throughout your participation.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China